Chemical formula: C₁₉H₂₈NO₃+ Molecular mass: 318.431 g/mol PubChem compound: 9933193
Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
ATC code | Group title | Classification |
---|---|---|
A03AB02 | Glycopyrronium bromide | A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS → A03AB Synthetic anticholinergics, quaternary ammonium compounds |
D11AA01 | D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AA Antihidrotics | |
R03BB06 | R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics | |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Title | Information Source | Document Type | |
---|---|---|---|
CUVPOSA Oral solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
TOVANOR Inhalation powder, hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC |
Glycopyrronium is an active ingredient of these brands:
United States (US)
Australia (AU)Austria (AT)
Brazil (BR)Canada (CA)Croatia (HR)
Estonia (EE)
Finland (FI)
France (FR)
Hong Kong (HK)Ireland (IE)
Israel (IL)
Italy (IT)
Japan (JP)Lithuania (LT)
Netherlands (NL)
New Zealand (NZ)Poland (PL)
Romania (RO)
South Africa (ZA)
Spain (ES)
Turkey (TR)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.